Merger Markets analyst on CNBC Says Quest Diagnostics (DGX) Looking at Counter-Bid for Fisher Scientific (FSH)
Merger Markets analyst on CNBC said Quest Diagnostics Inc. (NYSE: DGX) is taking a strong interest in making a counter-bid for Fisher Scientific International Inc. (NYSE: FSH), which currently has a merger deal with Thermo Electron Corp. (NYSE: TMO).
0 Comments:
Post a Comment
<< Home